Oral disodium cromoglycate in mastocytosis

Acta Derm Venereol. 1981;61(3):272-3.

Abstract

Oral disodium cromoglycate was found useful for the treatment of gastrointestinal manifestations of mastocytosis in 2 patients with systemic disease. The urinary excretion of histamine in these 2 patients decreased following treatment. Oral disodium cromoglycate had no effect on cutaneous symptoms, either in these 2 patients nor in 2 other patients with urticaria pigmentosa without signs of systemic mastocytosis. In the latter 2 patients the urinary excretion of histamine was unaffected. Treatment was given for 4 to 6 weeks and the dose of disodium cromoglycate was 100 mg four times daily in the 3 adult patients and 100 mg three times daily in the fourth patient, an 8-year-old boy.

MeSH terms

  • Administration, Oral
  • Adult
  • Child
  • Cromolyn Sodium / therapeutic use*
  • Female
  • Histamine / urine
  • Humans
  • Male
  • Middle Aged
  • Urticaria Pigmentosa / drug therapy*
  • Urticaria Pigmentosa / urine

Substances

  • Histamine
  • Cromolyn Sodium